Hypertension Clinical Trial
To correlate dietary factors and changes in pressor substances, including aldosterone and norepinephrine, with blood pressure during growth and sexual development from childhood through adolescence.
BACKGROUND:
Blood pressure increases with age, and over time, reaches proportions consistent with
clinically defined hypertension in some individuals. The age-dependent increase in blood
pressure starts in mid-childhood and accelerates during puberty and in the post-pubertal
period. Thus, mechanisms for the development of hypertension are likely present at an early
age. The National Heart, Lung, and Blood Institute sponsored the 'Workshop on Juvenile
Hypertension' in May 1983. The Workshop conclusions were that although a great deal had been
accomplished in the past decade, research in juvenile hypertension had slowed and little
effort was evident in some important areas of the field. They noted especially the paucity
of effort in research relating to mechanisms of blood pressure regulation and elevation, to
clinical management of the hypertensive state, and to identification of the prehypertensive
state. Based on the recommendations of the Workshop, this study was initiated in response to
a Request for Applications on 'Juvenile Hypertension and the Prehypertensive State' released
by the NHLBI in October 1984.
DESIGN NARRATIVE:
Production of aldosterone and norepinephrine is examined in a mixed-longitudinal study
design in white and Black boys and girls beginning at ages 6 to 12 and extending to age 17.
Levels of these pressor systems are determined in the basal state from measurements made in
urine samples collected overnight. To enhance the likelihood that school children would
comply with the multiple observations required for this longitudinal study, measurements are
deliberately restricted to non-invasive ones. Specifically, aldosterone and norepinephrine
excretion measured in sleep urine are obtained at six month intervals in addition to blood
pressure, heart rate, weight, height, and skin-fold thickness. Family history of
hypertension and parental blood pressures are used as covariates in analysis of data in
children. A second part of the study concerns the observation that blood pressure increases
at a faster rate during adrenarche, a period of increasing adrenal androgen production, and
during puberty. Androgen production during periods of adrenal and gonadal maturation may
contribute to the increase in blood pressure. The relationship of androgen to blood pressure
is examined by distinguishing blood pressure responses to androgen production from effects
of androgens on physical growth, thus exploring the concept that androgens interact directly
with pressor systems to raise blood pressure. Androgen production during the adrenarche is
determined by measurement of dehydroepiandrosterone-sulfate excretion, and during puberty by
measurement of luteinizing hormone excretion in sleep urine samples. Studies continue on the
relationship between aldosterone excretion rate, dietary potassium intake, and blood
pressure. A cross-over study is conducted to examine the effect of potassium supplementation
on aldosterone production. Segregation analysis of the 'low-aldosterone'phenotype is
performed on family members of children with low-aldosterone.
The study was renewed in 1996 to continue the longitudinal study of children (a biracial
population, ages 6-16 years) for whom influences of hormones on blood pressure are being
examined. Twice yearly the children have had blood pressure and anthropometrics measured,
and overnight urine samples collected for measurement of aldosterone, adrenal androgens
(AA), luteinizing hormone (LH), sodium, potassium, and creatinine. Rates of growth and the
changes in blood pressure with age have been well characterized for this population. From
the original observations, several differences were observed between racial groups;
specifically, Black children were found to consume less potassium, produce about 40 percent
less aldosterone and have higher blood pressures than white children. It was observed that
children with positive families histories of hypertension were more likely to have lower
aldosterone-excretion rates.
As part of the proposed continuation of longitudinal studies, the hypothesis is tested that
children with low-aldosterone levels are predisposed to higher blood pressures. Although
Black children had lower potassium intakes, cross-sectional data indicated that only part of
the racial difference in aldosterone production was secondary to a lower intake of potassium
(potassium is a known stimulus of aldosterone production). Subjects with known
low-aldosterone production (Blacks and whites) have diets supplemented with potassium to
test the hypothesis that Blacks with low-aldosterone production have a reduced
responsiveness to potassium when compared to white children with low-aldosterone. Families
of children with potassium-resistant low-aldosterone production are screened for evidence of
low-aldosterone production, and segregation analyses is performed to establish the mode of
inheritance of the 'low-aldosterone' phenotype. In cross-sectional studies, AA-excretion
rates were positively related to blood pressure in subjects greater than or equal to 10
years of age, suggesting an important role for the adrenarche in determining blood pressure
levels in young people. In future longitudinal studies the role of AA as well as gonadal
hormones will be studied as more children reach adolescence (the current mean age of the
cohort is 12.7 yr). In addition, to better distinguish the individual influences of
adrenarche, gonadarche, and increases in body size on blood pressure, a series of patients
where these phenomenon are dissociated will be studied.
The study was renewed in FY 2002 to identify new mechanisms for hypertension using a
strategy which identifies the sodium transporters in kidney that account for why blacks
retain more sodium than whites. Three sites along the nephron will be studied based on
compelling evidence that they are linked to the increased sodium-retention in blacks.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |